This report is an analysis of an anonymous patient’s medications and how they relate to his health issues. Please note that the patient will be referred to as patient Afib in order to protect his privacy. Patient Afib is a 58 year old male with a recent onset of atrial fibrillation (AF) that has been cured using ablation and antiarrhythmic medications. This report discusses how physicians treated patient Afib’s AF, the medications patient Afib is currently taking and their mechanism of action, and how these medications relate to the patient’s disease. Medications discussed in this analysis include Proair HFA, Multaq, Toprol XL, and Coumadin. Proair HFA, a rescue inhaler used to treat asthma, was prescribed to patient Afib in order to determine if AF or underlying asthma caused his shortness of breath. Multaq is an antiarrhythmic drug used to keep patient Afib in a normal sinus rhythm. Toprol XL is a medication used in the treatment of hypertension that also exhibits rate controlling properties which prove beneficial for patient Afib. Coumadin, an anticoagulant, is used to reduce the risk of stroke for patient Afib should his AF ever spontaneously return without his knowledge. Patient Afib does not like the regime of pills he is required to take but understands their necessity. Patient Overview Patient Afib is a 58 year old, Caucasian, married male. The patient has been healthy most of his life with no significant health issues until the
S.D. was admitted to the telemetry unit and an IV amiodarone drip was started. The purpose of the drug was to convert her atrial fibrillation to normal sinus rhythm. Although her heart rate has decreased to 108 beats/minute, she remains in atrial fibrillation 24 hours later. A cardiologist was consulted and electrical cardioversion is
Physical Examination: General: The patient is an alert, oriented male appearing his stated age. He appears to be in moderate distress. Vital signs: blood pressure 132/78 and pulse 68 and regular. Temperature is 38.56 oC (101.4 oF). HEENT:Normocephalic, atraumatic. Pupils were equal, round, and reactive to light. Ears are clear. Throat is normal. Neck: The neck is supple with no carotid bruits. Lungs: The lungs are clear to auscultation and percussion. Heart: Regular rate and rhythm. Abdomen:Bowel sounds are normal. There is rebound tenderness with maximal discomfort on palpation in the right lower quadrant. Extremities: No clubbing, cyanosis, or edema.
This report is Part 1 of assignment for Marketing MBA 565-MBOL1 to Dr. Stephen Baglione
* Registers may only be kept electronically if safeguards are built into the software to ensure the following:
A 68 year old male presented to the emergency department at 0800 hours via ambulance after experiencing chest discomfort and intermittent palpitations since 0500 hours. Prior to presentation, the patient stated he
1. Identify potential sources of synergy in the proposed acquisition of Star Genomics. Identify a set of problems that the acquisition may create. How can Pills & Co. address them? From the strategic viewpoint, does it appear to be a sensible acquisition for Pills & Co.?
1. There are a number of types of materials and equipment needed for the administration of medication via the different routes. They all serve a type and purpose these include:
‘Only nurses with relevant knowledge, competence, skills and experience in nursing children should prescribe for children. This is particularly important in primary care (e.g. out of hours, walk-in clinics and general practice settings). Any one prescribing for a child in these situations must be able to demonstrate competence in prescribing for children and refer to another prescriber when working outside their level of expertise or level of competence.’ The Nursing and Midwifery Council standards of proficiency for nurse and midwife prescribers’ (NMC, 2006)
The Medicines Act 1968:- The Medicines Act controls the manufacture and supply of medicines for human and veterinary use. The act defines three categories of the supply of drugs; Prescription only medicines, Pharmacy Medicine, and General sales list medicines the act controls
“Non-medical prescribing is prescribing which is taken by a health professional who is not a doctor” (Non-medical prescribing 2012).To become a non-medical prescriber the relevant training must be undertaken to ensure the patients’ safety is most important. The health care professional who is the non-medical prescribers is only legally allowed to prescribe within their area of expertise and they must remain competent within that area, through maintenance of various continuing education and training programmes.
Maureen shows clinical manifestations such as hypotension (BP 80 mmHg systolic), tachycardia (HR 120 bpm and irregular), tachypnea (Resps 28 bpm), SaO2 unreadable, capillary refill time >4secs, temp 36.5°C (core) indicating the signs of hypovolaemia (Perner & Backer, 2014, p. 614). With the reference of Mrs. Hardy’s medical condition, such as arthritic knees and atrial fibrillation (INR 2.7), she is under diclofenac Acid 50mgs PO BD and warfarin 2mgs PO mane respectively (Jordan, 2010, p. 567; Zacher, et al., 2008, p. 930). Diclofenac is a
- Patient is afebrile, meaning "no fever". No signs of infection. This eliminates answer choices: Acute fibrinous pericarditis and Endocardial fibrosis.
The intended use of medications is meant to improve a person’ health, it is very important the individual administering medication or self-medicating use the drugs correctly, by following the doctors’ instruction for the medication prescribed. Medication is given to diagnose, treat, and prevent illness. Medication can be very dangerous, which can potentially cause harm or even deaf if it’s not used properly.
Presently, the evolving comprehensive research labors toward comprehending atrial fibrillation(Afib) is guided by epidemiologic results by gaining a better comprehension the natural history of the disease. As most diseases being researched there appears to be a growing "epidemic" and Afib is among those diseases that has substantial influence on morbidity and mortality in addition to the socioeconomic outcomes in association to hospital admissions, chronic disease management and disabilities(Chugh et al, 2014). Therefore, gaining a solid grasp of the epidemiology and natural history of AFib is critical to the future management of this disease.
In our experience with Pharmasim we learned that Marketing decision making must be very sensitive and responsive to everything going on in the industry which is very complex. Consumer responses to marketing tactics can be volatile and unpredictable and no idea is guaranteed to work well. Marketing is a matter of meticulous research, assumptions, planning, and volatility at times. Overall we took away two major points: 1) that it is important to consider the product lifecycle in evaluating how to promote businesses and, 2) that the “Sweet Spot” as a competitive advantage should be the greatest point of consideration when evaluating how to best gain leverage to beat the competition in the minds of